110 studies found for:    "Choreatic Disorders" OR "McLeod neuroacanthocytosis syndrome" OR "Neuroacanthocytosis" OR "Chorea Acanthocytosis Syndromes"
Show Display Options
Rank Status Study
21 Recruiting Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Drug: Placebo
22 Recruiting A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Pridopidine;   Other: Placebo
23 Unknown  UW/VA Madison Brain Bank
Conditions: Alzheimer's Disease;   Parkinson's Disease;   ALS;   Multiple Sclerosis;   Huntington's Disease
Intervention:
24 Completed Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
Condition: Huntington Disease
Interventions: Drug: PBT2;   Drug: Placebo
25 Completed Creatine Therapy for Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Creatine
26 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
27 Completed A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
Condition: Huntington Disease
Interventions: Drug: Dimebon;   Other: Placebo
28 Completed A Phase II Safety and Tolerability Study With SEN0014196
Condition: Huntington's Disease
Interventions: Drug: SEN0014196;   Drug: Placebo
29 Completed A Study of ACR16 for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
30 Completed
Has Results
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
Condition: Huntington's Disease
Intervention:
31 Recruiting Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Condition: Huntington's Disease
Interventions: Drug: Creatine Monohydrate;   Drug: Placebo
32 Completed Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
Condition: Huntington's Disease
Intervention: Drug: Creatine Monohydrate
33 Unknown  MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease
Condition: Huntington Disease
Intervention: Procedure: graft intracerebral of foetal neurons
34 Not yet recruiting Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients
Condition: Huntington's Disease
Interventions: Drug: BN82451B;   Drug: Placebo
35 Completed A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
Conditions: Alzheimer's Disease;   Huntington's Disease
Interventions: Drug: Warfarin;   Drug: Dimebon
36 Not yet recruiting Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers
Condition: Huntington's Disease
Interventions: Drug: PBF-999;   Drug: Placebo
37 Recruiting Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical Patients
Conditions: Pain;   Huntington Disease;   Hepatic Surgery
Intervention:
38 Completed
Has Results
Creatine Safety & Tolerability in Huntington's Disease
Condition: Huntington's Disease (HD)
Intervention: Drug: Creatine monohydrate
39 Recruiting Brain Structure and Function in Children at Risk for Huntington's Disease
Condition: Huntington's Disease
Intervention:
40 Completed Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
Condition: Huntington's Disease
Intervention: Procedure: Stimulation

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years